Abbott Laboratories reached a pact with U.S. authorities that would allow it to begin making baby formula again at a troubled plant in Michigan, a move that could help ease a supply shortfall that has rattled many parents.
The official line coming out of Covid-hit Shanghai is that business is returning to usual despite the ongoing lockdown, yet hundreds of manufacturers in the city aren’t operating at anywhere near to full capacity, if they’re up and running again at all.
At a time when companies will do just about anything to recruit and retain workers, fertility benefits have gone from novelty to a must-have for many companies.
The Biden administration will allow all pharmacies to order Pfizer Inc.’s COVID-19 therapy pill, as it looks to boost access to the promising drug as the supply increases.
After racing to build capacity and meet once seemingly insatiable orders for COVID-19 shots, the global vaccine industry is facing waning demand as many late-to-market producers fight over a slowing market.
Johnson & Johnson suspended the supply of its personal-care products in Russia due to the “increasing scale of the humanitarian crisis” caused by the war in Ukraine.
There’s little room for error in most global supply chains, but none for the pharmaceutical cold chain. Failure is measured in lost revenue, reputation and potentially patient lives.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.